Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker.
el-Fawal
H A
HA
Institute of Environmental Medicine, New York University Medical Center, Tuxedo Park 10987.
Ehrich
M F
MF
D000704:Analysis of Variance; D000818:Animals; D015415:Biomarkers; D002118:Calcium / Q000378:metabolism; D002154:Calpain / Q000032:analysis / Q000378:metabolism*; D002645:Chickens; D004950:Esterases / Q000032:analysis; D005260:Female; D007306:Insecticides / Q000633:toxicity*; D009132:Muscles / Q000187:drug effects / Q000201:enzymology; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D009498:Neurotoxins / Q000633:toxicity*; D009943:Organophosphorus Compounds / Q000633:toxicity*; D012584:Sciatic Nerve / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D014317:Tritolyl Phosphates / Q000633:toxicity*; D014700:Verapamil / Q000494:pharmacology*
D015415:Biomarkers; D007306:Insecticides; D009498:Neurotoxins; D009943:Organophosphorus Compounds; D014317:Tritolyl Phosphates; C046357:phenylsaligenin cyclic phosphate; D014700:Verapamil; D004950:Esterases; D002154:Calpain; D002118:Calcium; C025541:tri-o-cresyl phosphate